Ya’an Kang

7.9k citations

53 papers · 3.9k indexed · 1 hit paper · h-index 31

Impact in

Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis

Papers in

Cancer Research 16
- Cancer, Hypoxia, and Metabolism 7
Oncology 26
- Pancreatic and Hepatic Oncology Research 19
- Cancer Cells and Metastasis 10

Co-authors: Jason B. Fleming Haoqiang Ying Matteo Ligorio Xiaoxu Wang Cristina R. Ferrone Costas A. Lyssiotis Marcia C. Haigis Sujun Hua
Journals: Clinical Cancer Research (7 papers)Surgery (2 papers)Archives of Biochemistry and Biophysics (2 papers)Cancer Letters (2 papers)Cancer Research (2 papers)
Partner nations: United States China Japan

In The Last Decade

Ya’an Kang

53 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway 2013 · 1.5k citations

Peers

Countries citing papers authored by Ya’an Kang

Since Specialization

Citations

This map shows the geographic impact of Ya’an Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya’an Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya’an Kang more than expected).

Fields of papers citing papers by Ya’an Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya’an Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya’an Kang. The network helps show where Ya’an Kang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ya’an Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ya’an Kang Line = papers co-authored together Ya’an Kang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition Cancer Research ·Yan Liang, Bo Tu, Jun Yao, Jing Gong, Alessandro Carugo, Christopher A. Bristow, Qiuyun Wang, Cihui Zhu, Bingbing Dai, Ya’an Kang, Leng Han, Ningping Feng, Shelley Jh, Jason B. Fleming, Timothy P. Heffernan, Wantong Yao, Haoqiang Ying	2021	30
2	DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis JCI Insight ·Jenying Deng, Ya’an Kang, Ioan Brukner, Xinqun Li, Bingbing Dai, Matthew H. G. Katz, Taoyan Men, Michael P. Kim, Eugene J. Koay, Huocong Huang, Rolf A. Brekken, Jason B. Fleming	2021	89
3	Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway Cell Death and Disease ·Bingbing Dai, Jithesh J. Augustine, Ya’an Kang, David Roife, Xinqun Li, Jenying Deng, Lin Tan, 小尻英博, John N. Weinstein, Philip L. Lorenzi, Michael P. Kim, Jason B. Fleming	2021	7
4	Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors Clinical Cancer Research ·Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, Liwei Chen, Perry Kennedy, Muhammad Ayaz, Steven Fletcher, Christopher T. Cummings, Harshani R. Lawrence, Francisca Beato, Ya’an Kang, Michael P. Kim, Andrea E. Delitto, Patrick W. Underwood, Jason B. Fleming, José G. Treviño, Andrew D. Hamilton, Saı̈d M. Sebti	2019	53
5	Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer JCI Insight ·Meifang Yu, Nicholas D. Nguyen, Yanqing Huang, Daniel Lin, Tara N. Fujimoto, Jessica M. Molkentine, Amit Deorukhkar, Ya’an Kang, F. Anthony San Lucas, Yong Qiang Benjamin Tan, Eugene J. Koay, Sonal Gupta, Haoqiang Ying, Albert C. Koong, Joseph M. Herman, Jason B. Fleming, Anirban Maitra, Cullen M. Taniguchi	2019	129
6	Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer Journal of Proteome Research ·Prasanta Dutta, Marcos Antonio Viana dos Santos, Jae-Hyuk Lee, Ya’an Kang, Michael Pratt, Travis C. Salzillo, Joseph Weygand, Niki M. Zacharias, Seth T. Gammon, Eugene J. Koay, Michael P. Kim, Florencia McAllister, Subrata Sen, Anirban Maitra, David Piwnica‐Worms, Jason B. Fleming, Pratip K. Bhattacharya	2019	25
7	SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy Clinical Cancer Research ·Feng Wang, Xiaojun Xia, Chunying Yang, Viet Chinh, Junhua Mai, L. G. P. de Souza, Dickson Kirui, Ya’an Kang, Jason B. Fleming, Eugene J. Koay, Sankar Mitra, Mauro Ferrari, Haifa Shen	2018	123
8	Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy Biomaterials ·Jun Zhao, Huamin Wang, AM Minns, Diana S‐L Chow, Eugene J. Koay, Ya’an Kang, Xiaoxia Wen, Qian Huang, Ying Ma, James A. Bankson, Stephen E. Ullrich, Willem W. Overwijk, Anirban Maitra, David Piwnica‐Worms, Jason B. Fleming, Chun Li	2018	110
9	Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant type Laboratory Investigation ·Tommy Ivanics, John R. Bergquist, Gang Liu, Michael P. Kim, Ya’an Kang, Matthew H. G. Katz, Dendy Syaiful Akbar, Ryan M. Thomas, Jason B. Fleming, Mark J. Truty	2018	33
10	Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma Molecular Cancer Therapeutics ·Bingbing Dai, David Roife, Ya’an Kang, Joy Gumin, Dendy Syaiful Akbar, Xinqun Li, Michael Pratt, Rolf A. Brekken, Juàn Fueyo, Frederick F. Lang, Jason B. Fleming	2017	17
11	Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy Surgery ·David Roife, Ya’an Kang, Li Wang, Bingliang Fang, Stephen G. Swisher, Jeffrey E. Gershenwald, Shanna Pretzsch, Colin P. Dinney, Matthew H. G. Katz, Jason B. Fleming	2017	18
12	Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism Oncology Reports ·Tao Shan, Shuo Chen, Xi Chen, 真美子岡田, Wei Li, Jiancang Ma, Tao Wu, Xijuan Cui, Hong Ji, Yiming Li, Ya’an Kang	2017	91
13	Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors Clinical Cancer Research ·Ya’an Kang, David Roife, Yeon‐Ju Lee, 宏一松尾, Rei Suzuki, Jianhua Ling, Dendy Syaiful Akbar, Xinqun Li, Bingbing Dai, Michael Pratt, Mark J. Truty, Deyali Chatterjee, Huamin Wang, Ryan M. Thomas, Yu Wang, Eugene J. Koay, Paul J. Chiao, Matthew H. G. Katz, Jason B. Fleming	2016	29
14	Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma Clinical Cancer Research ·David Roife, Bingbing Dai, Ya’an Kang, Dendy Syaiful Akbar, Michael Pratt, Xinqun Li, Jason B. Fleming	2016	46
15	Extracellular Lumican Inhibits Pancreatic Cancer Cell Growth and Is Associated with Prolonged Survival after Surgery Clinical Cancer Research ·Xinqun Li, Hussien H. Kasem, Ya’an Kang, Xavier Chopin‐Laly, Ran Zhang, David Roife, Deyali Chatterjee, E. Lin, Ryan M. Thomas, Huamin Wang, Matthew H. G. Katz, Jason B. Fleming	2014	69
16	The Canary in the Coal Mine: The Growth of Patient-Derived Tumorgrafts in Mice Predicts Clinical Recurrence after Surgical Resection of Pancreatic Ductal Adenocarcinoma Annals of Surgical Oncology ·Ryan M. Thomas, Mark J. Truty, Michael P. Kim, Ya’an Kang, Ran Zhang, Deyali Chatterjee, Matthew H. G. Katz, Jason B. Fleming	2014	22
17	TrkBT1 Induces Liver Metastasis of Pancreatic Cancer Cells by Sequestering Rho GDP Dissociation Inhibitor and Promoting RhoA Activation Cancer Research ·Zhongkui Li, Zhe Chang, bla, Ya’an Kang, Qianghua Xia, Cihui Zhu, Jason B. Fleming, Douglas B. Evans, Paul J. Chiao	2009	45
18	An Orthotopic Model of Papillary Thyroid Carcinoma in Athymic Nude Mice Archives of Otolaryngology - Head and Neck Surgery ·Soon‐Hyun Ahn, Ying C. Henderson, Ya’an Kang, Chandrani Chattopadhyay, Alexandra Tomkinson, Mary Wang, Katrina Briggs, Gary L. Clayman	2008	41
19	Human LBP-32/MGR is a Repressor of the P450scc in Human Choriocarcinoma Cell Line JEG-3 Placenta ·Ying C. Henderson, Mitchell J. Frederick, Arumugam Jayakumar, Yongmun Choi, Fangyuan Song, Ya’an Kang, Randall Evans, Paul M. Spring, Motonari Uesugi, Gary L. Clayman	2006	12
20	Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution Archives of Biochemistry and Biophysics ·Arumugam Jayakumar, Ya’an Kang, Ying C. Henderson, Kenji Mitsudo, Xiaoling Liu, Katrina Briggs, Mary Wang, Mitchell J. Frederick, Adel K. El‐Naggar, Zsuzsa Bebők, Gary L. Clayman	2004	19

About Ya’an Kang

Ya’an Kang is a scholar working on Cancer Research, Oncology, Biotechnology, Cell Biology and Immunology, having authored 53 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (19 papers), Cancer Cells and Metastasis (10 papers), Cancer, Hypoxia, and Metabolism (7 papers), Epigenetics and DNA Methylation (6 papers), Cancer Research and Treatments (5 papers), 3D Printing in Biomedical Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Skin and Cellular Biology Research (3 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (1.4k citations), Molecular Biology (2.2k citations), Immunology (576 citations) and Biotechnology (224 citations). Ya’an Kang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Jason B. Fleming, Haoqiang Ying, Matteo Ligorio, Xiaoxu Wang, Cristina R. Ferrone, Costas A. Lyssiotis, Marcia C. Haigis, Sujun Hua, Nabeel Bardeesy and Alec C. Kimmelman. Their work appears in journals such as Clinical Cancer Research, Surgery, Archives of Biochemistry and Biophysics, Cancer Letters and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact